ANI PHARMACEUTICALS, INC Total Long-Term Debt
ANI PHARMACEUTICALS, INC (ANIP) had Total Long-Term Debt of $134.10 million as of 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2018-11-06
- 2018-09-30: Long-term Debt $134.10M.
- 2018-06-30: Long-term Debt $132.10M.
- 2018-03-31: Long-term Debt $130.20M.
- 2017-12-31: Long-term Debt $128.21M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2018-09-30 | $134.10M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $132.10M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $130.20M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $128.21M 10-K · filed 2018-02-27 | |
| 2017-09-30 | $126.28M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $124.38M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $122.50M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $120.64M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $118.81M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $116.99M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $115.20M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $113.43M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $115.19M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $113.67M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $112.17M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $106.54M 10-K · filed 2016-02-23 | $110.69M 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |